Thus, our results confirmed the bioinformatically predicted GD2-positive status of pituitary adenoma cells and suggest the possibility of using GD2-targeted therapy for the treatment of pituitary ACTH-secreting tumors. Here, POMC is linked to pituitary gland adenoma.